What is the share price of Chandra Bhagat Pharma Ltd (CBPL) today?
The share price of CBPL as on 16th June 2025 is ₹56.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Chandra Bhagat Pharma Ltd (CBPL) share?
The past returns of Chandra Bhagat Pharma Ltd (CBPL) share are- Past 1 week: -2.59%
- Past 1 month: 0.89%
- Past 3 months: -9.74%
- Past 6 months: -13.08%
- Past 1 year: -40.78%
- Past 3 years: -38.35%
- Past 5 years: 22.83%
What are the peers or stocks similar to Chandra Bhagat Pharma Ltd (CBPL)?
The peers or stocks similar to Chandra Bhagat Pharma Ltd (CBPL) include:What is the market cap of Chandra Bhagat Pharma Ltd (CBPL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chandra Bhagat Pharma Ltd (CBPL) is ₹42.63 Cr as of 16th June 2025.What is the 52 week high and low of Chandra Bhagat Pharma Ltd (CBPL) share?
The 52-week high of Chandra Bhagat Pharma Ltd (CBPL) is ₹101.45 and the 52-week low is ₹46.15.What is the PE and PB ratio of Chandra Bhagat Pharma Ltd (CBPL) stock?
The P/E (price-to-earnings) ratio of Chandra Bhagat Pharma Ltd (CBPL) is 49.57. The P/B (price-to-book) ratio is 1.47.Which sector does Chandra Bhagat Pharma Ltd (CBPL) belong to?
Chandra Bhagat Pharma Ltd (CBPL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Chandra Bhagat Pharma Ltd (CBPL) shares?
You can directly buy Chandra Bhagat Pharma Ltd (CBPL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Chandra Bhagat Pharma Ltd
CBPL Share Price
56.500.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CBPL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CBPL Performance & Key Metrics
CBPL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.47 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.40 | 6.69 | 0.83% |
CBPL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CBPL Company Profile
Chandra Bhagat Pharma Ltd markets pharmaceutical critical care products, focusing on formulations for hospitals and healthcare centers, including injections and active pharmaceutical ingredients.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
8.50%
8.50%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.39
23.39
1Y Return
4.53%
4.53%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
19.82
19.82
1Y Return
10.06%
10.06%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
58.02
58.02
1Y Return
12.77%
12.77%
Buy Reco %
72.00
72.00
ZYDUSLIFE
PE Ratio
21.67
21.67
1Y Return
11.24%
11.24%
Buy Reco %
46.43
46.43
CBPL Forecast
CBPL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CBPL
CBPL
Income
Balance Sheet
Cash Flow
Annual Normal View
CBPL Income Statement
CBPL Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 90.28 | 97.73 | 106.72 | 94.42 | 71.18 | 95.70 | 119.96 | 232.70 | 92.24 | — | ||||||||||
Raw Materials | 79.16 | 88.28 | 103.64 | 86.26 | 53.78 | 81.44 | 104.57 | 209.06 | 88.17 | — | ||||||||||
| Power & Fuel Cost | 0.09 | 0.09 | 0.09 | 0.08 | 0.05 | 0.07 | 0.07 | 0.09 | ||||||||||||
| Employee Cost | 5.64 | 5.02 | 4.53 | 2.25 | 1.85 | 1.52 | 1.32 | 2.18 | ||||||||||||
| Selling & Administrative Expenses | 4.62 | 4.65 | 4.22 | 2.42 | 4.85 | 5.45 | 7.30 | 17.75 | ||||||||||||
| Operating & Other expenses | -4.10 | -5.57 | -10.80 | -0.15 | 6.48 | 2.76 | 3.08 | -0.66 | ||||||||||||
EBITDA | 4.87 | 5.26 | 5.04 | 3.56 | 4.17 | 4.46 | 3.62 | 4.28 | 4.07 | — | ||||||||||
| Depreciation/Amortization | 0.14 | 0.06 | 0.05 | 0.03 | 0.12 | 0.12 | 0.27 | 0.64 | 0.95 | — | ||||||||||
| PBIT | 4.73 | 5.20 | 4.99 | 3.53 | 4.05 | 4.34 | 3.35 | 3.64 | 3.12 | — | ||||||||||
| Interest & Other Items | 3.81 | 3.67 | 4.09 | 3.11 | 3.76 | 3.24 | 2.20 | 1.39 | 1.95 | — | ||||||||||
| PBT | 0.92 | 1.53 | 0.90 | 0.42 | 0.29 | 1.10 | 1.15 | 2.25 | 1.17 | — | ||||||||||
| Taxes & Other Items | 0.25 | 0.50 | 0.20 | 0.11 | 0.09 | 0.30 | 0.25 | 0.74 | 0.31 | — | ||||||||||
| Net Income | 0.67 | 1.03 | 0.70 | 0.31 | 0.20 | 0.80 | 0.90 | 1.51 | 0.86 | — | ||||||||||
| EPS | 16.03 | 24.64 | 12.86 | 0.75 | 0.27 | 1.06 | 1.19 | 2.00 | 1.14 | — | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
CBPL Company Updates
CBPL Stock Peers
CBPL Past Performance & Peer Comparison
CBPL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Chandra Bhagat Pharma Ltd | 49.57 | 1.47 | — |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.39 | 4.60 | 1.05% |
| Dr Reddy's Laboratories Ltd | 19.82 | 3.97 | 0.60% |
CBPL Stock Price Comparison
Compare CBPL with any stock or ETFCompare CBPL with any stock or ETF
CBPL
CBPL Holdings
CBPL Shareholdings
CBPL Promoter Holdings Trend
CBPL Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.91%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CBPL Institutional Holdings Trend
CBPL Institutional Holdings Trend
No institutional holdings trend are available
CBPL Shareholding Pattern
CBPL Shareholding Pattern
CBPL Shareholding History
CBPL Shareholding History
Foreign Institutions
smallcases containing CBPL stock
smallcases containing CBPL stock
Looks like this stock is not in any smallcase yet.
CBPL Events
CBPL Events
CBPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CBPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CBPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CBPL has not given any dividends in last 5 years
CBPL Dividends
CBPL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCBPL Stock News & Opinions
CBPL Stock News & Opinions
Articles & Videos
Corporate
Chandra Bhagat Pharma to conduct board meeting
Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Chandra Bhagat Pharma schedules board meeting
Chandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Chandra Bhagat Pharma to conduct AGM
Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Chandra Bhagat Pharma schedules AGM
Chandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.87%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0.05% to 0.06%
Over the last 5 years, net income has grown at a yearly rate of 16.62%, vs industry avg of 15.29%